MAM
TBI

Marquette Asset Management’s Trueblue TBI Stock Holding History

Marquette Asset Management’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572K Buy
+82,019
New +$457K 0.07% 42

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IH
IES Holdings Houston, Texas $311M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marquette Asset Management's TBI Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Trueblue (TBI) in Q2 2026: 82,019 shares worth $572K. The stake represents 0.07% of the portfolio and ranks #42 among its holdings.

114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Marquette Asset Management held 82,019 shares of Trueblue worth $572K as of Q2 2026.
  • Trueblue was a new Marquette Asset Management position in Q2 2026.
  • Trueblue made up 0.07% of Marquette Asset Management's portfolio in Q2 2026, its #42 holding.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.